21 CFR Part 210: Current Good Manufacturing Practices for Drugs
PART 210 outlines CGMP regulations to ensure drug safety and quality, with non-compliance leading to regulatory action. It includes additional rules for HCT/Ps and defines key terms for clarity in manufacturing processes. Compliance is required only for specific operations conducted.